Related Experiment Video
Updated: May 23, 2025

Author Spotlight: Optimization of Ultrashort Peptide Matrices for Colorectal Cancer Organoids
Published on: May 3, 2024
Self-Assembly of Short Peptides Activates Specific ER-Phagy and Induces Pyroptosis for Enhanced Tumor Immunotherapy
Yunhua Zhang1, Chengyuan Qian2, Chengyan Chu2
1State Key Laboratory of Coordination Chemistry, School of Chemistry and Chemical Engineering, Chemistry and Biomedicine Innovation Center (ChemBIC), ChemBioMed Interdisciplinary Research Center, Nanjing University, Nanjing, Jiangsu, 210023, P.R. China.
Abstract:
Developing specific endoplasmic reticulum-autophagy (ER-phagy) inducers is highly desirable for discovering new ER-phagy receptors and elucidating the detailed ER-phagy mechanism and potential cancer immunotherapy. However, most of the current ER-phagy-inducing methods cause nonselective autophagy of other organelles. In this work, we report the design and synthesis of simple and stable short peptides (D-FFxFFs) that could specifically trigger ER-phagy, which further induces pyroptosis and activates the immune response against tumor cells. D-FFxFFs locate preferentially in ER and readily self-assemble to form nanosized misfolded protein mimics, which lead to distinct upregulation of dedicated ER-phagy receptors with no obvious autophagy of other organelles. Significant unfolded protein response (UPR) is activated via IRE1-JNK and PERK-ATF4 pathways. Interestingly, the persistent ER-phagy triggers ER Ca2+ release and a surge in mitochondrial Ca2+ levels, resulting in GSDMD-mediated pyroptosis other than apoptosis. The ER-phagy induces pyroptosis and activates a distinct antitumor immune response without evolving the acquired drug resistance. This work not only provides a powerful tool for investigating the mechanism and function of ER-phagy but also offers an appealing strategy for anticancer immunotherapy.
Insights
Researchers developed specific short peptides (D-FFxFFs) to induce endoplasmic reticulum-autophagy (ER-phagy). This targeted approach activates pyroptosis and an antitumor immune response, offering a novel cancer immunotherapy strategy.
Area of Science:
- Cellular Biology
- Molecular Mechanisms
- Immunology
Background:
- Developing specific endoplasmic reticulum-autophagy (ER-phagy) inducers is crucial for understanding ER-phagy mechanisms and cancer immunotherapy.
- Current methods often lead to nonselective autophagy, affecting other organelles.
Purpose of the Study:
- To design and synthesize novel, specific ER-phagy inducers.
- To investigate their potential in cancer immunotherapy by triggering pyroptosis and immune responses.
Main Methods:
- Design and synthesis of simple, stable short peptides (D-FFxFFs).
- Assessment of peptide localization and self-assembly in the endoplasmic reticulum (ER).
- Analysis of ER-phagy receptor upregulation, unfolded protein response (UPR) activation, and pyroptosis induction.
Main Results:
- D-FFxFFs specifically induce ER-phagy without affecting other organelles.
- Peptides activate UPR via IRE1-JNK and PERK-ATF4 pathways.
- ER-phagy triggers ER calcium release, leading to GSDMD-mediated pyroptosis and a distinct antitumor immune response.
Conclusions:
- D-FFxFFs serve as effective tools for studying ER-phagy mechanisms.
- This peptide-based strategy offers a promising approach for cancer immunotherapy, inducing pyroptosis and antitumor immunity without acquired drug resistance.
Related Concept Videos
Tumor Immunotherapy
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
The Extrinsic Apoptotic Pathway
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Mitogens and the Cell Cycle
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized...

